Technological breakthroughs in Regmed according to a Global Strategic Business Report

Research and Markets has announced the addition of Regenerative Medicine – Global Strategic Business Report to their offering for EUR 3,407.00. Link

“This report analyzes the worldwide markets for Regenerative Medicine in Millions of US$. The report provides separate comprehensive analytics for the US, Japan, Europe, Canada, and Asia-Pacific, and Rest of World. Annual forecasts are provided for each region for the period of 2003 through 2010. The report profiles 107 companies including many key and niche players worldwide. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.”

In this research focused industry I’d like to highlight the content of chapter 4 of the Business Report on technological innovations in regmed: how many of them have you ever heard?

4. Technological Innovations / Breakthroughs II-27
Biovest International Launches AutovaxID™ II-27
Stelic Institute Announces New Treatment Method for Acute Liver Failure II-27
TissueGene Initiates Phase 1 Clinical Trials for TG-C II-27
ISTO Announces FDA’s IND Approval for Neocartilage Graft II-28
Cook Biotech Introduces Surgisis® AFP™ Anal Fistula Plug II-28
Korean Scientists Make a Major Breakthrough in Stem Cell Lines II-28
Japanese Researchers Regenerate Jaw Bone II-28
Geron Researchers Differentiate Hepatocytes from hESCs II-29
Geron Demonstrates Potential of hESCs in Treatment of Parkinson’s disease II-29
Geron Researches Cardiomyocytes for Heart Disease II-29
Endovasc Announces New Findings at Texas Heart Institute Research II-29
Geron and Celera Genomics Complete Characterization of Active Genes in hESCs II-30
Rockefeller University Develops Solution for Maintaining Plupotency in hESCs II-30
Somatic Cell Nuclear Transfer II-31
Manipulating Cells to Develop Tissue II-31
Terumo All Set to Regenerate Cardiac Muscle Tissues II-31
ThermoGenesis Innovates Bioengineered Cornea Cell Implant II-32
Organ Rejection Risk Minimized by Filtering Antibodies from Blood II-32
Regenerative Medicine for Acute Renal Failure Patients II-33
Tepha Develops PHA4400 Thermoplastic Polyester Biomaterial II-33
Regenerated Eye Transplantation Mastered in Tadpoles II-34
Investigations on Role of Microgravity in Regenerative Medicine II-34
Geron Researches Derivation of Neurons and Neural Progenitors from hESCs II-34

Kyoto University Develops Hybrid Pluripotent Cells for Regenerative Medicine II-35
DeveloGen Uses Developmental Biology with Focus on Regenerative Medicine II-35
Curis Develops Chondrogel Treatment for Vesicoureteral Reflux II-36